PAH in practice: Putting patients first
The faculty will give guidance on which patients are candidates for receiving selexipag, and provide practical insights on how to introduce the drug, especially keeping in mind the benefits for patients and the long-term therapeutic goals. The ‘typical’ patient’s experience with selexipag will be included.
- To apply the multidisciplinary approach, with a focus on the patient's perspective to the use of selexipag in clinical practice
- Professor Stephan Rosenkranz